Carlsbad, CA, United States of America

Costas Loullis

This inventor holds 2 USPTO granted patents. Top assignee: Ancile Pharmaceuticals, Inc.. Active years: 2002-2003.


% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2002-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Costas Loullis: Innovator in the Treatment of Restless Leg Syndrome

Introduction

Costas Loullis is a notable inventor based in Carlsbad, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of Restless Leg Syndrome (RLS) and related disorders. With a total of 2 patents, Loullis is dedicated to improving the quality of life for those affected by this condition.

Latest Patents

Loullis's latest patents focus on the use of Valeriana for the treatment of Restless Leg Syndrome and its related disorders. One of his patents discloses a method of inhibiting at least one symptomology of RLS, including periodic limb movements in sleep (PLMS) and periodic limb movement disorder (PLMD). This method involves identifying a host afflicted with RLS and administering a pharmaceutically effective amount of Valeriana. The patent also details the administration of specific compounds found in Valeriana extracts, such as 10(14)-Aromadendren-4-ol and Valerenic acid, to diminish undesired limb movements.

Career Highlights

Costas Loullis is currently associated with Ancile Pharmaceuticals, Inc., where he continues to innovate in the field of pharmacology. His work is characterized by a commitment to developing effective treatments for conditions that significantly impact patients' lives.

Collaborations

Loullis collaborates with Keith Hoffman, contributing to the advancement of research and development in their field. Their partnership exemplifies the importance of teamwork in driving innovation.

Conclusion

Costas Loullis is a dedicated inventor whose work in the treatment of Restless Leg Syndrome showcases his commitment to improving patient outcomes. His innovative approaches and collaborations highlight the potential for advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…